Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Respiratory Syncytial Virus Infection: Why Does Disease Severity Vary Among Individuals? Publisher Pubmed



Tahamtan A1, 2 ; Samadizadeh S2 ; Rastegar M2 ; Nakstad B3 ; Salimi V4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Infectious Diseases Research Centre, Golestan University of Medical Sciences, Gorgan, Iran
  2. 2. Department of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
  3. 3. Institute of Clinical Medicine, University of Oslo, Oslo, Norway
  4. 4. Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Source: Expert Review of Respiratory Medicine Published:2020


Abstract

Introduction: Respiratory syncytial virus (RSV) is the most common cause of acute lower respiratory tract infections in infancy. While many infants are infected with RSV, the nature and severity of the disease vary among individuals. RSV causes bronchiolitis, pneumonia, and asthma exacerbation. However, most children infected with RSV have only mild upper airways disease and may be asymptomatic. Areas covered: Despite efforts to elucidate mechanisms for the various clinical responses to RSV infection, they remain largely unknown, suggesting that susceptibility and disease are influenced by multiple intrinsic and extrinsic factors. This article reviews the available literature on the field of RSV disease severity and discusses important factors associated to susceptibility and different disease outcome. Expert opinion: The severity of RSV-induced illness is a phenomenon that depends on a variety of graded mechanisms of interaction between the host, virus, and environment. This may lead to differences in the intensity of immune response in the lung and different courses of the disease. By characterizing, classifying, and grading the affecting factors in high-risk patients versus those who do not fall ill by RSV, we may find therapies or point to disease-limiting medications. © 2020, © 2020 Informa UK Limited, trading as Taylor & Francis Group.
Other Related Docs
17. The Molecular Epidemiology of Respiratory Viruses in Military Trainees in Iran, Medical Journal of the Islamic Republic of Iran (2019)
26. Opioids and Viral Infections: A Double-Edged Sword, Frontiers in Microbiology (2016)